Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaChaolin Huang, Bin Cao, Jungang Xie et al.|The Lancet|2020Cited by 51.8k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialYeming Wang, Chen Wang, Dingyu Zhang et al.|The Lancet|2020Cited by 3.7k
Risk factors for severity and mortality in adult COVID-19 inpatients in WuhanXiaochen Li, Jianping Zhao|Journal of Allergy and Clinical Immunology|2020Cited by 2.4k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyChen Wang, Jiang He, Jianying Xu et al.|The Lancet|2018Cited by 1.7k
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive studyLi-li Ren, Jianwei Wang, Ye-Ming Wang et al.|Chinese Medical Journal|2020Cited by 1.4k